Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
BridgeBio Oncology Therapeutics Inc.
Market Cap
$285.18M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$285.98M
EBITDA Margin
-1475.69%
TTM Avg
-1475.69%
3Y Avg
-2002.71%
5Y Avg
-1922.41%
Market Cap
$281.16M
EBITDA Margin
-25.38%
TTM Avg
-1946.60%
3Y Avg
-1509.96%
5Y Avg
-1364.90%
Market Cap
$278.58M
EBITDA Margin
-2082.59%
TTM Avg
-1743.06%
3Y Avg
-1015.79%
5Y Avg
-806.48%
Market Cap
$276.26M
EBITDA Margin
-13.37%
TTM Avg
-2.68%
3Y Avg
-19.85%
5Y Avg
-36.16%
Market Cap
$274.05M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$302.66M
EBITDA Margin
-24933.33%
TTM Avg
-24426.94%
3Y Avg
-19832.71%
5Y Avg
-13250.84%
Market Cap
$266.17M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics Inc. (BBOT) | $285.18M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.98M | -1475.69% | -1475.69% | -2002.71% | -1922.41% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.87M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.16M | -25.38% | -1946.60% | -1509.96% | -1364.90% |
| Fate Therapeutics, Inc. (FATE)vs › | $278.58M | -2082.59% | -1743.06% | -1015.79% | -806.48% |
| Aurora Cannabis Inc. (ACB)vs › | $276.26M | -13.37% | -2.68% | -19.85% | -36.16% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $274.05M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $302.66M | -24933.33% | -24426.94% | -19832.71% | -13250.84% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.17M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $309.45M | -101.16% | -95.97% | -88.25% | -69.69% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
